J. Capellan

Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects.

R. Couch, T. Cate, R. Belshe, 2007, Vaccine.

Randomized, Double-Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High-Dose and Standard-Dose Influenza Vaccine in Adults 65 Years of Age and Older

A. Falsey, J. Treanor, G. Gorse, 2009 .

A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or =65 years of age.

J. Langley, A. McGeer, J. Capellan, 2009, Vaccine.

Elective treatment of bleeding varices with the Sugiura operation over 10 years.

M. Mercado, H. Orozco, G. Garcia‐Tsao, 1992, American journal of surgery.

Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals.

E. Walsh, A. Falsey, F. Hayden, 2008, The Journal of infectious diseases.

Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older.

A. Falsey, J. Treanor, G. Gorse, 2009, The Journal of infectious diseases.

The validity of classic symptoms and chest radiographic configuration in predicting pulmonary tuberculosis.

R. Cohen, J. Capellan, J. Capellan, 1996, Chest.